Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a variant (change) in the HPDL gene
- The diagnosis may fall under one of several condition names, including HPDL-related hereditary spastic paraplegia (HSP), HPDL-related neonatal mitochondrial encephalopathy, Spastic paraplegia-83 (SPG83), or a neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (NEDSWMA)
Who may not be able to join:
- People who have a known genetic abnormality other than a change in the HPDL gene
- People who have any other condition that the trial doctor believes could put them at undue risk or prevent them from completing all parts of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joseph Gleeson, UCSD
Phone: 8582460547
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinician questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.